In 2012, the Japanese market for urological devices was valued at $411.9 million.This report analyzes the markets for the treatment of benign prostate hyperplasia (BPH), prostate cancer, urinary incontinence as well as urinary and kidney stones. Other markets analyzed include urodynamic equipment and urological endoscopes. In 2012, the prostate cancer treatment device market was both the largest and fastest-growing segment in the total Japanese market for urological devices. Procedure volume growth in the market is expected to increase over the 2012 ? 2019 forecast period due to the expected rise in the aging population of the baby boom generation as well as increases in early diagnosis....
No comments:
Post a Comment